Estrogen receptors and cathepsin D in human thyroid tissue

Area of Science:

• Endocrinology
• Oncology
• Molecular Biology

Background:

• Estrogen receptors (ER) and related proteins are implicated in various cancers.
• Investigating ER and estrogen-regulated proteins in thyroid dysplasia is crucial for understanding pathogenesis.
• This study analyzes ER, progesterone receptor (PR), cathepsin D, and pS2 protein in human thyroid tissues.

Purpose of the Study:

• To determine the role of estrogen receptors (ER) in thyroid dysplasia.
• To analyze the expression of ER, PR, cathepsin D, and pS2 protein in various thyroid tissue types.
• To compare these markers between neoplastic and non-neoplastic thyroid tissues.

Main Methods:

• Analyzed 42 human thyroid tissue cytosols, including normal, benign nodules, toxic adenomas, Graves disease, and carcinomas.
• Measured ER and PR using an immunoenzymatic assay.
• Quantified cathepsin D and pS2 protein via an immunoradiometric assay.

Main Results:

• Estrogen receptors (ER) showed no significant difference between neoplastic and non-neoplastic thyroid tissues.
• Cathepsin D levels were significantly higher in carcinomas, Graves disease, and toxic adenomas compared to normal tissues.
• Cathepsin D concentrations correlated with tumor size in carcinomas (pT4 vs. pT2/pT3).
• Progesterone receptor (PR) and pS2 protein were undetectable in all tested tissues.

Conclusions:

• Cathepsin D is significantly elevated in neoplastic and certain non-neoplastic thyroid conditions, unlike ER.
• Estrogen does not appear to regulate cathepsin D in thyroid tissues.
• Cathepsin D may serve as a marker for protease activity during thyroid carcinoma invasion.